Help us: Donate
Follow us on:
×

Mainstreaming genetic counselling for ovarian cancer

Mainstreaming genetic counselling for ovarian cancer

LUGANO, 17 November 2017 – A study that looked at mainstreaming genetic counselling for ovarian cancer to support screening programmes in Malaysia was presented at the ESMO Asia 2017 Congress. (1) The preliminary results of the MaGiC study show that most patients counselled by a well-trained but not necessarily an expert in genetics were satisfied or just as satisfied with their experience as compared to those being counselled by a genetic counsellor or clinical geneticist.

One in nine ovarian cancer patients carries the BRCA1 or BRCA2 (breast cancer gene 1 or 2) mutation and four in 10 carriers do not have a family history of breast or ovarian cancer. (2) Knowing one’s BRCA status may indicate how one may respond to certain therapies or the level of risk to develop certain cancers.

“In the past, genetic testing in ovarian cancer was limited to a small number of patients with the aim of identifying relatives at risk,” said Dr Soo Chin Lee, Senior Consultant, National University Cancer Institute, Singapore, commenting on the study. “Now that there is a drug to treat cancer patients with BRCA mutations, genetic counselling and testing is recommended for all patients with epithelial ovarian cancer. This

read more...




Article originally posted at

www.eurekalert.org

Click here for the full story




Category